Table 1.
Patient characteristics
| Characteristics | All patients, n = 75 | Real acupuncture, n = 27 | Sham acupuncture, n = 24 | Usual care, n = 24 |
|---|---|---|---|---|
| Age, median (range) | 59.7 (36.3–85.9) | 60.3 (51.0–79.7) | 62.7 (43.0–86.0) | 57.3 (36.3–70.6) |
| Gender | ||||
| Male | 15 (20) | 7 (26) | 5 (21) | 3 (12) |
| Female | 60 (80) | 20 (74) | 19 (79) | 21 (88) |
| BMI, median (range) | 28.7 (19.8–46) | 30.2 (20.2–46) | 27.9 (19.8–39.5) | 27.8 (21.1–35.1) |
| Race | ||||
| White | 55 (73) | 22 (81) | 22 (92) | 11 (46) |
| Black | 13 (17) | 4 (15) | 0 | 9 (38) |
| Asian | 3 (4) | 0 | 2 (8) | 1 (4) |
| Unknown | 4 (5) | 1 (4) | 0 | 3 (12) |
| Hispanic ethnicity | 7 (9) | 3 (11) | 1 (4) | 3 (12) |
| Cancer type | ||||
| Breast | 40 (53) | 13 (48) | 11 (46) | 16 (67) |
| Lung | 1 (1) | 0 | 0 | 1 (4) |
| Colon/rectal | 12 (16) | 5 (18) | 6 (25) | 1 (4) |
| Testicular | 5 (7) | 4 (15) | 0 | 1 (4) |
| Melanoma | 1 (1) | 0 | 0 | 1 (4) |
| Head/neck | 1 (1) | 0 | 1 (4) | 0 |
| Ovarian | 4 (5) | 2 (7) | 2 (8) | 0 |
| Cervical | 1 (1) | 0 | 0 | 1 (4) |
| Pancreatic | 1 (1) | 0 | 1 (4) | 0 |
| Endometrial | 6 (8) | 3 (11) | 2 (8) | 1 (4) |
| Squamous cell | 1 (1) | 0 | 0 | 1 (4) |
| Stomach | 1 (1) | 0 | 1 (4) | 0 |
| Uterine | 1 (1) | 0 | 0 | 1 (4) |
| Cancer stage | ||||
| Stage I | 14 (19) | 7 (26) | 1 (4) | 6 (25) |
| Stage II | 35 (47) | 12 (44) | 13 (54) | 10 (42) |
| Stage III | 22 (29) | 7 (26) | 9 (38) | 6 (25) |
| Stage IV | 4 (5) | 1 (4) | 1 (4) | 2 (8) |
| Chemo type | ||||
| Taxane‐based only | 39 (52) | 13 (48) | 11 (46) | 15 (62) |
| Platinum‐based only | 20 (27) | 8 (30) | 9 (38) | 3 (12) |
| Taxane and platinum combined | 16 (21) | 6 (22) | 4 (17) | 6 (25) |
| Years since chemo, median (range) | 3.8 (0.3–40.8) | 5.4 (0.5–40.8) | 3.0 (0.3–12.2) | 3.3 (0.3–11.4) |
Values are reported as no. (%) unless otherwise indicated.
Abbreviation: BMI, body mass index.